Ecron Acunova to offer end-to-end capabilities as 'Navitas Life Sciences'

With consolidation of Take's legacy brand Navitas and Intelnet

Take Solutions intimated that its subsidiary Ecron Acunova and a globally recognised full service CRO with Clinical and Bioavailablity/ Bioequivalence expertise, announced that it would be consolidating its capabilities with TAKE's niche Life Sciences brand Navitas and Intelnet to form a unified go to market brand - Navitas Life Sciences.

Powered by Capital Market - Live News